<DOC>
	<DOC>NCT02273479</DOC>
	<brief_summary>Study to investigate pharmacokinetics, pharmacodynamics and safety of RAD-SP capsule in multiple administration to healthy adult male volunteers.</brief_summary>
	<brief_title>Pharmacokinetics and Safety of Asasantin Extended Release (RAD-SP) Capsules in Japanese Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Aspirin, Dipyridamole Drug Combination</mesh_term>
	<criteria>Healthy male volunteers judged by the investigator as appropriate subjects on the basis of screening test results Age range: ≥ 20 years and ≤ 35 years Body weight between 50 and 80 kg Obesity is within ± 20% of the standard body weight Ability to provide written informed consent to participate in the study History of drug allergy History of bronchial asthma History of drug abuse and alcohol abuse History of hemorrhagic tendency or hemorrhagic disease Volunteers who have experiences in playing sports such as boxing which may damage the brain Accidents associated with brain concussion and contusion (traffic accident, etc.) Administration of other study drug within 4 months before start of administration of this study drug Collection of whole blood (≥ 400 ml) within 3 months before study drug administration Collection of component blood (≥ 400 ml) within 1 months before study drug administration Intake of some drug or other within 10 days before the study drug administration Excessive physical activities within the last 5 days prior to study drug administration Intake of alcohol within 3 days before study drug administration Volunteers judged by the investigator to be inappropriate as the subjects of study</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>